Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Sell

C

Akoya BioSciences, Inc. Common Stock (AKYA)

Laboratory Analytical Instruments

https://www.akoyabio.com

Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers the comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. The company has its geographical presence in North America, APAC and EMEA. It generates majority of the revenue from North America.

100 CAMPUS DRIVE, 6TH FLOOR
MARLBOROUGH, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/16/2021

Market Cap

112,116,368

Shares Outstanding

49,080,000

Weighted SO

49,076,173

Total Employees

N/A

Upcoming Earnings

08/05/2024

Similar Tickers

ATRC --.--%

ATRI --.--%

ICUI --.--%

HAE --.--%

ANGO --.--%

ATR --.--%

COO --.--%

INFU --.--%

Beta

1.3460

Last Div

0.0000

Range

1.88-6.31

Chg

0.0750

Avg Vol

324117

Mkt Cap

112116368

Exch

NASDAQ

Country

US

Phone

855 896 8401

DCF Diff

5.0210

DCF

-0.0310

Div Yield

0.0000

P/S

1.2028

EV Multiple

-4.3126

P/FV

5.0311

Div Yield %

0.0000

P/E

-1.8548

PEG

-0.0779

Payout

0.0000

Current Ratio

2.7342

Quick Ratio

1.9768

Cash Ratio

0.2726

DSO

64.8194

DIO

218.4591

Op Cycle

283.2785

DPO

86.2083

CCC

197.0702

Gross Margin

0.5556

Op Margin

-0.5193

Pretax Margin

-0.6463

Net Margin

-0.6474

Eff Tax Rate

-0.0012

ROA

-0.4198

ROE

-1.4141

ROCE

-0.4361

NI/EBT

1.0017

EBT/EBIT

1.2446

EBIT/Rev

-0.5193

Debt Ratio

0.5496

D/E

3.5510

LT Debt/Cap

0.7728

Total Debt/Cap

0.7803

Int Coverage

-806.7833

CF/Debt

-0.6477

Equity Multi

6.4607

Rec Turnover

5.6310

Pay Turnover

4.2339

Inv Turnover

1.6708

FA Turnover

6.4411

Asset Turnover

0.6485

OCF/Share

-1.0354

FCF/Share

-1.0841

Cash/Share

0.9151

OCF/Sales

-0.5489

FCF/OCF

1.0470

CF Coverage

-0.6477

ST Coverage

-15.4031

CapEx Coverage

-21.2672

Div&CapEx Cov

-21.2672

P/BV

5.0311

P/B

5.0311

P/S

1.2028

P/E

-1.8548

P/FCF

-2.0927

P/OCF

-2.1876

P/CF

-2.1876

PEG

-0.0779

P/S

1.2028

EV Multiple

-4.3126

P/FV

5.0311

DPS

0.0000

Latest Headlines (EST)

Benzinga Apr 23, 00:45 $TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of GB, YOTA, PORT, AKYA to Act GlobeNewswire Inc. Apr 04, 23:00 $HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN, SLRN, AKYA, SHYF GlobeNewswire Inc. Jan 07, 08:00 Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow GlobeNewswire Inc. Jan 07, 08:00 Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook GlobeNewswire Inc. Jan 07, 08:00 Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform GlobeNewswire Inc. Jan 07, 08:00 Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow GlobeNewswire Inc. Jan 07, 08:00 Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook GlobeNewswire Inc. Jan 07, 08:00 Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform GlobeNewswire Inc. Jan 07, 08:00 Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow GlobeNewswire Inc. Jan 07, 08:00 Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook GlobeNewswire Inc. Jan 07, 08:00 Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform Benzinga Nov 13, 10:00 Expert Ratings for Akoya Biosciences

Revenue Product Segmentation